Label

How We Work

Grant

Back

Print

National Center for Genetic Engineering and Biotechnology


May 2009
to develop and test a novel drug that binds to the two pathways used by the DHFR enzyme in P. falciparum to mutate. By tethering these active sites, the dual-binding drug will suppress the development of resistance to anti-malarial drugs.
$100,000
18
Discovery and Translational Sciences
Global Health
Pathumthani
http://www.biotec.or.th/biotechnology-en/en/index.asp

Visit Our Blog